A detailed history of Boston Trust Walden Corp transactions in Zoetis Inc. stock. As of the latest transaction made, Boston Trust Walden Corp holds 42,959 shares of ZTS stock, worth $7.08 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
42,959
Previous 43,563 1.39%
Holding current value
$7.08 Million
Previous $7.55 Million 11.14%
% of portfolio
0.06%
Previous 0.06%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$172.58 - $196.48 $104,238 - $118,673
-604 Reduced 1.39%
42,959 $8.39 Million
Q2 2024

Jul 19, 2024

SELL
$145.54 - $178.83 $388,591 - $477,476
-2,670 Reduced 5.78%
43,563 $7.55 Million
Q1 2024

Apr 22, 2024

SELL
$165.67 - $199.94 $6.83 Million - $8.24 Million
-41,229 Reduced 47.14%
46,233 $7.82 Million
Q4 2023

Jan 24, 2024

BUY
$151.44 - $200.09 $62,544 - $82,637
413 Added 0.47%
87,462 $17.3 Million
Q3 2023

Oct 18, 2023

SELL
$167.14 - $192.77 $368,543 - $425,057
-2,205 Reduced 2.47%
87,049 $15.1 Million
Q2 2023

Jul 24, 2023

BUY
$160.94 - $186.23 $155,468 - $179,898
966 Added 1.09%
89,254 $15.4 Million
Q1 2023

Apr 19, 2023

BUY
$145.48 - $175.02 $1.53 Million - $1.84 Million
10,530 Added 13.54%
88,288 $14.7 Million
Q4 2022

Jan 20, 2023

BUY
$131.14 - $157.47 $406,533 - $488,157
3,100 Added 4.15%
77,758 $0
Q3 2022

Oct 19, 2022

BUY
$148.29 - $182.55 $73,551 - $90,544
496 Added 0.67%
74,658 $11.1 Million
Q2 2022

Jul 22, 2022

BUY
$155.97 - $200.09 $1.08 Million - $1.39 Million
6,954 Added 10.35%
74,162 $12.7 Million
Q1 2022

Apr 20, 2022

BUY
$181.39 - $234.03 $327,590 - $422,658
1,806 Added 2.76%
67,208 $12.7 Million
Q4 2021

Jan 21, 2022

SELL
$193.69 - $247.03 $134,614 - $171,685
-695 Reduced 1.05%
65,402 $16 Million
Q3 2021

Oct 25, 2021

BUY
$189.29 - $209.69 $618,599 - $685,266
3,268 Added 5.2%
66,097 $12.8 Million
Q2 2021

Jul 22, 2021

BUY
$155.9 - $187.99 $2.56 Million - $3.08 Million
16,407 Added 35.34%
62,829 $11.7 Million
Q1 2021

Apr 21, 2021

BUY
$144.0 - $169.39 $375,984 - $442,277
2,611 Added 5.96%
46,422 $7.31 Million
Q4 2020

Jan 15, 2021

SELL
$157.07 - $174.35 $6,125 - $6,799
-39 Reduced 0.09%
43,811 $7.25 Million
Q3 2020

Oct 14, 2020

BUY
$137.1 - $165.37 $122,156 - $147,344
891 Added 2.07%
43,850 $7.25 Million
Q2 2020

Jul 23, 2020

BUY
$111.92 - $142.53 $845,891 - $1.08 Million
7,558 Added 21.35%
42,959 $5.89 Million
Q1 2020

Apr 21, 2020

SELL
$92.66 - $144.94 $175,312 - $274,226
-1,892 Reduced 5.07%
35,401 $4.17 Million
Q4 2019

Jan 10, 2020

SELL
$116.25 - $133.25 $28,132 - $32,246
-242 Reduced 0.64%
37,293 $4.94 Million
Q3 2019

Oct 21, 2019

SELL
$112.57 - $128.43 $24,202 - $27,612
-215 Reduced 0.57%
37,535 $4.68 Million
Q2 2019

Jul 25, 2019

BUY
$97.98 - $114.28 $109,737 - $127,993
1,120 Added 3.06%
37,750 $4.28 Million
Q1 2019

Apr 16, 2019

BUY
$81.56 - $100.67 $2.68 Million - $3.3 Million
32,830 Added 863.95%
36,630 $3.69 Million
Q3 2017

Oct 13, 2017

BUY
$59.73 - $65.4 $226,974 - $248,520
3,800
3,800 $242,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Boston Trust Walden Corp Portfolio

Follow Boston Trust Walden Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.